| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |